Kevin Petrecca, MD, PhD, FRCS(C)
Kevin PetreccaÌýconsacre sa pratique clinique à traiter des personnes atteintes d’un cancer du cerveau et son programme de recherche à 1) l’étude de l’origine, du développement et des propriétés des cellules souches du cancer du cerveau et 2) la mise au point de nouveaux outils pour opérer des tumeurs au cerveau.
Highly Accurate Detection of Cancer In Situ with Intraoperative, Label-Free, Multimodal Optical Spectroscopy. Jermyn M, Mercier J, Aubertin K, Desroches J, Urmey K, Karamchandiani J, Marple E, Guiot MC, Leblond F, Petrecca K.ÌýCancer Research. 2017;77:3942-3950.
Raman spectroscopy detects distant invasive brain cancer cells centimeters beyond MRI capability in humans. Jermyn M, Desroches J, Mercier J, St-Arnaud K, Guiot MC, Leblond F, Petrecca K. Biomedical Optics Express. 2016;7:5129-5137.
A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma. Shenouda G, Souhami L, Petrecca K, Owen S, Panet-Raymond V, Guiot MC, Corredor AG, Abdulkarim B. International Journal of Radiation Oncology, Biology, Physics. 201797:487-494.
Intraoperative brain cancer detection with Raman spectroscopy in humans.ÌýJermyn M, Mok K, Mercier J, Desroches J, Pichette J, Saint-Arnaud K, Bernstein L, Guiot MC, Petrecca K, Leblond F. Science Translational Medicine. 2015;7:274.
DRR regulates AKT activation to drive brain cancer invasion. Dudley A, Sater M, Le PU, Trinh G, Sadr MS, Bergeron J, Deleavey GF, Bedell B, Damha MJ, Petrecca K. Oncogene. 2014;33:4952-60.
DRR drives brain cancer invasion by regulating cytoskeletal-focal adhesion dynamics. Le PU, Angers-Loustau A, de Oliveira RM, Ajlan A, Brassard CL, Dudley A, Brent H, Siu V, Trinh G, Mölenkamp G, Wang J, Seyed Sadr M, Bedell B, Del Maestro RF, Petrecca K. Oncogene. 2010;29:4636-4